tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BCRX Stock Latest News

BioCryst price target raised to $18 from $16 at JMP Securities
The FlyBioCryst price target raised to $18 from $16 at JMP Securities
16d ago
BCRX
BioCryst launches Orladeyo in ireland
PremiumThe Fly
BioCryst launches Orladeyo in ireland
1M ago
BCRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
BCRX
NKTR
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
2M ago
BCRX
BioCryst price target raised to $8 from $7 at Barclays
PremiumThe Fly
BioCryst price target raised to $8 from $7 at Barclays
2M ago
BCRX
BioCryst Pharmaceuticals Reports Strong Q3 2024 Results
PremiumCompany AnnouncementsBioCryst Pharmaceuticals Reports Strong Q3 2024 Results
2M ago
BCRX
Nvidia to replace Intel on DJIA, Berkshire reports Q3 results: Morning Buzz
Premium
The Fly
Nvidia to replace Intel on DJIA, Berkshire reports Q3 results: Morning Buzz
2M ago
BX
CC
BioCryst Announces Strong Q3 2024 Revenue Growth
Premium
Company Announcements
BioCryst Announces Strong Q3 2024 Revenue Growth
2M ago
8K
BCRX
BioCryst reports Q3 EPS (7c), consensus (6c)
PremiumThe Fly
BioCryst reports Q3 EPS (7c), consensus (6c)
2M ago
BCRX
BioCryst sees FY24 ORLADEYO revenue $430M-$435M
PremiumThe Fly
BioCryst sees FY24 ORLADEYO revenue $430M-$435M
2M ago
BCRX
BioCryst sees FY24 total product revenue guidance $443M-$448M
PremiumThe Fly
BioCryst sees FY24 total product revenue guidance $443M-$448M
2M ago
BCRX
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
2M ago
BCRX
BioCryst presents evidence on high adherence, persistence rates with ORLADEYO
PremiumThe FlyBioCryst presents evidence on high adherence, persistence rates with ORLADEYO
2M ago
BCRX
BioCryst to present real-world evidence on oral ORLADEYO
Premium
The Fly
BioCryst to present real-world evidence on oral ORLADEYO
2M ago
BCRX
Two Key Products Drive BioCryst (BCRX) to New Highs
Premium
Market News
Two Key Products Drive BioCryst (BCRX) to New Highs
3M ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
3M ago
BCRX
BioCryst Begins Phase 1 Trial for Netherton Syndrome Treatment
PremiumCompany Announcements
BioCryst Begins Phase 1 Trial for Netherton Syndrome Treatment
3M ago
8K
BCRX
BioCryst begins enrollment for Phase 1 trial evaluating BCX17725
PremiumThe Fly
BioCryst begins enrollment for Phase 1 trial evaluating BCX17725
3M ago
BCRX
BioCryst Secures Major US Health Department Influenza Drug Deal
PremiumCompany Announcements
BioCryst Secures Major US Health Department Influenza Drug Deal
3M ago
8K
BCRX
BioCryst awarded $69M RAPIVAB contract by U.S. government
PremiumThe FlyBioCryst awarded $69M RAPIVAB contract by U.S. government
3M ago
BCRX
BioCryst completes negotiations with pCPA for PrORLADEYO
Premium
The Fly
BioCryst completes negotiations with pCPA for PrORLADEYO
3M ago
BCRX
BioCryst presents first interim real-word evidence from APeX-N trial
Premium
The Fly
BioCryst presents first interim real-word evidence from APeX-N trial
4M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >